Christopher Dell, Vice-President of Business Development at HLS Therapeutics Inc, holds 100.00K shares in HLS Therapeutics Inc (Ticker: TSE:HLS). Most recently, Christopher Dell Sold C$14,700 shares of HLS Therapeutics Inc on Dec 03, 2015 for an estimated value of 36.75K.